Newsletter | October 3, 2025

10.03.25 -- Improving Cardiovascular Outcomes

FEATURED PODCAST

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

On this Business Of Biotech episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical trials during ambulance rides to the hospital, with the goal of preserving heart function and reducing mortality related to acute cardiovascular events, including heart attacks.

INDUSTRY INSIGHTS

Data Analytics' Role In Driving Commercialization And Clinical Success

Advanced analytics enable life sciences companies to optimize the trials, facilitating data-driven decisions that significantly reduce the time and financial burdens associated with drug development.

The Right CRO Is An Extension Of Your Brand: Here's Why It Matters

For sponsors eyeing Australia, CROs with deep local expertise unlock the region’s advantages and, coupled with a global outlook, can ensure your trial aligns with international regulatory expectations.

Biotech Landscape Continues To Shift

Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.

Can Condition-Based Matching Shift The Trial Recruitment Paradigm?

Condition-based matching is replacing the inefficient, study-by-study model with a patient-centric approach that matches individuals to all relevant trials based on their unique medical profiles.

From Paper To Performance: Smart Manufacturing And Quality Excellence

As the digital backbone for real-time production control and data integrity, see how a manufacturing execution system (MES) orchestrates production processes from start to finish.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.